🔎 Trials Near Me

Domov › Rak debelega črevesa › Ohio

Klinične študije za Rak debelega črevesa v Ohio

23 študij za Rak debelega črevesa išče udeležence na lokacijah v Ohio.

Mesta v Ohio

Uradno besedilo študije (angleško)

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

  • Good Samaritan Hospital - Cincinnati, Cincinnati
  • Bethesda North Hospital, Cincinnati
  • TriHealth Cancer Institute-Westside, Cincinnati
  • in še 1
Vključevanje udeležencevVabljeni zdravi prostovoljci
Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07283939

Family Communications After Genetic Testing

  • Aultman Alliance Community Hospital, Alliance
  • Indu and Raj Soin Medical Center, Beavercreek
  • Saint Elizabeth Boardman Hospital, Boardman
  • in še 17
Vključevanje udeležencevVabljeni zdravi prostovoljci
Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07143487

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

  • Miami Valley Hospital South ( Site 0075), Centerville
  • University of Cincinnati Medical Center ( Site 2005), Cincinnati
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06997497

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

  • ALX Center 10, Columbus
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07085091

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

  • Oncology Hematology Care - Eastgate, Cincinnati
  • University Hospitals Cleveland Medical Center, Cleveland
  • Oncology Hematology Care Clinical Trials, LLC, Fairfield
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07222800

A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

  • GSK Investigational Site, Canton
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07213609

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

  • University of Cincinnati Cancer Institute, Cincinnati
  • Case Comprehensive Cancer Center, Cleveland
  • Ohio State University-Arthur G James Comprehensive Cancer Center, Columbus
  • in še 2
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 15. sep. 2026 · NCT07284849

EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.

  • University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland
Vključevanje udeležencev
Starost 18 in več · Vsi spoli · Posodobljeno 15. sep. 2026 · NCT06263088

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

  • Cleveland Clinic, Cleveland
  • Toledo Clinic Cancer Center, Toledo
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT05059444

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

  • UHHS-Chagrin Highlands Medical Center, Beachwood
  • Miami Valley Hospital South, Centerville
  • Good Samaritan Hospital - Cincinnati, Cincinnati
  • in še 13
Vključevanje udeležencev
Starost 45–70 · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT05080673

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

  • Summa Health System - Akron Campus, Akron
  • Cleveland Clinic Akron General, Akron
  • Aultman Alliance Community Hospital, Alliance
  • in še 65
Vključevanje udeležencevFaza 2/3
Starost 18 in več · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT05174169

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

  • Xencor Investigative Site, Cincinnati
  • Xencor Investigative Site, Columbus
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 3. avg. 2026 · NCT05433142

Strategies for Optimizing a Mailed FIT Program in Appalachia

  • Ohio State University Comprehensive Cancer Center, Columbus
Vključevanje udeležencev
Starost 45–74 · Vsi spoli · Posodobljeno 9. jul. 2026 · NCT07173985

Integrated Cancer Repository for Cancer Research

  • Aultman Alliance Community Hospital, Alliance
  • Aultman Hospital, Canton
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 19–110 · Vsi spoli · Posodobljeno 29. jun. 2026 · NCT02012699

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

  • The Ohio State University Comprehensive Cancer Center, Columbus
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 12. jun. 2026 · NCT06051695

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

  • The Christ Hospital, Cincinnati
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 3. jun. 2026 · NCT06040541

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  • The Ohio State University Wexner Medical Center, Columbus
Vključevanje udeležencevFaza 1/2
Starost 12 in več · Vsi spoli · Posodobljeno 27. maj 2026 · NCT03093116

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

  • Christ Hospital Cancer Center, Cincinnati
  • Taylor Cancer Research Center, Maumee
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 15. maj 2026 · NCT05379985

Designing a Dyad-Based mHealth Intervention to Improve Adherence to Lifestyle Recommendations in Colorectal Cancer Survivors and Their Family Caregivers

  • Ohio State University Comprehensive Cancer Center, Columbus
Vključevanje udeležencevVabljeni zdravi prostovoljci
Starost 18 in več · Vsi spoli · Posodobljeno 9. apr. 2026 · NCT06746012

The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors

  • University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 9. apr. 2026 · NCT04624555

Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

  • GSK Investigational Site, Akron
  • GSK Investigational Site, Cincinnati
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 23. jan. 2026 · NCT05855200

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Cincinnati
  • Massive Bio SYNERGY-AI site, Columbus
  • Massive Bio SYNERGY-AI site, Mayfield Heights
Vključevanje udeležencevOpazovalna študija
Vse starosti · Vsi spoli · Posodobljeno 28. okt. 2025 · NCT03452774

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

  • The Ohio State University, Columbus
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2025 · NCT06682793

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.